CareLit Fachartikel

PAR-2 depletion protects against development of pulmonary hypertension

G Kwapiszewska, P Markart, LM Marsh, B Dahal, RT Schermuly, C Taube, A Meinhardt, HA Ghofrani, M Steinhoff, W Seeger, KT Preissner, N Weißmann, M Wygrecka · Pneumologie · 2012 · Heft 02

Dokument
1079699
CareLit-ID
Jahr
2012
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Pneumologie
Autor:innen
G Kwapiszewska, P Markart, LM Marsh, B Dahal, RT Schermuly, C Taube, A Meinhardt, HA Ghofrani, M Steinhoff, W Seeger, KT Preissner, N Weißmann, M Wygrecka
Ausgabe
Heft 02 / 2012
Seiten
–
Erschienen: 2012-02-23 00:00:00
ISSN
0934-8387

Zusammenfassung

Background: A hallmark of the vascular remodeling process underlying pulmonary hypertension (PH) is the aberrant proliferation and migration of pulmonary artery smooth muscle cells (PASMC). Accumulating evidence suggests that mast cell mediators play a role in the pathogenesis of PH. Therefore, in the present study we investigated the importance of protease-activated receptor (PAR)-2 and its ligand mast cell tryptase in the development of PH. Results: Our results revealed strong increase in PAR-2 and tryptase expression in the lungs of idiopathic pulmonary arterial hypertension (IPAH) patients, mice exposed to h…

Schlagworte

Pulmonary Artery Pneumologie